Regeneron Downgraded At Morgan Stanley; Better Biotech Peer Plays Elsewhere
October 02, 2015 at 10:24 AM EDT
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) have declined 11.33 percent in the last month, touching lows of $441.765 ...
